Link: https://links.sgx.com/1.0.0/corporate-announcements/4L4TFA4UKZC4LM6G/ba3fb4606967cd50107f4b96d603cc460c2fccd9fa34c23e15cbb6a18c39ec91

Summary:

• Q3 FY2026 revenue slipped 5% year-on-year to S$963,000 as the group closed loss-making retail outlets, though gross margin stayed relatively high at about 54% on a leaner store base and different product mix.

• Quarterly net loss narrowed 42% to S$148,000, while 9M FY2026 loss eased 14% to S$571,000, helped by sharply lower marketing and distribution spend and reduced finance costs after earlier debt waivers and lease exits.

• 9M revenue fell 16% to S$3.0 million, with corporate sales more than halved as the business shifted focus to core local retail and online health supplement sales.

• The group remains in a net liabilities position of S$5.8 million, with cash of just S$66,000 against S$3.0 million of borrowings, and continues to rely on interest-free loans and a financial support undertaking from major and controlling shareholders to stay a going concern.

• Management is reorganising the portfolio by shutting underperforming stores, redirecting customers to remaining outlets and digital channels, and reports improving online traction, but has withheld dividends and warns that uncertain macro conditions could weigh on consumer demand.